methadone has been researched along with Acute Disease in 48 studies
Methadone: A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)
methadone : A racemate comprising equimolar amounts of dextromethadone and levomethadone. It is a opioid analgesic which is used as a painkiller and as a substitute for heroin in the treatment of heroin addiction.
6-(dimethylamino)-4,4-diphenylheptan-3-one : A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "As methadone use increases, the potential for methadone-induced cardiotoxicity (MIC) may rise." | 7.96 | Acute right ventricular failure: a novel presentation of methadone-induced cardiotoxicity. ( Ahmed, MM; Al-Ani, M; Dasa, O; Radhakrishnan, NS; Taha, MB; Taha, OB, 2020) |
| "Empirical evidence is needed to guide adequate postpartum pain relief of methadone and buprenorphine stabilized patients." | 7.75 | Management of acute postpartum pain in patients maintained on methadone or buprenorphine during pregnancy. ( Dahne, J; Johnson, R; Jones, HE; Lemoine, L; Milio, L; O'Grady, K; Ordean, A; Selby, P, 2009) |
| "Methadone maintained treatment (MMT) patients may be given less opioid analgesia for acute pain than the general patient, due to requests for analgesia being misinterpreted as craving for drugs." | 7.74 | Management of acute pain in methadone maintenance therapy in-patients. ( Curry, K; Fong, D; Hines, S; Theodorou, S; Williamson, A, 2008) |
| "Undertreatment of acute pain is suboptimal medical treatment, and patients receiving long-term OAT are at particular risk." | 6.43 | Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. ( Alford, DP; Compton, P; Samet, JH, 2006) |
| "As methadone use increases, the potential for methadone-induced cardiotoxicity (MIC) may rise." | 3.96 | Acute right ventricular failure: a novel presentation of methadone-induced cardiotoxicity. ( Ahmed, MM; Al-Ani, M; Dasa, O; Radhakrishnan, NS; Taha, MB; Taha, OB, 2020) |
| "Empirical evidence is needed to guide adequate postpartum pain relief of methadone and buprenorphine stabilized patients." | 3.75 | Management of acute postpartum pain in patients maintained on methadone or buprenorphine during pregnancy. ( Dahne, J; Johnson, R; Jones, HE; Lemoine, L; Milio, L; O'Grady, K; Ordean, A; Selby, P, 2009) |
| "Methadone maintained treatment (MMT) patients may be given less opioid analgesia for acute pain than the general patient, due to requests for analgesia being misinterpreted as craving for drugs." | 3.74 | Management of acute pain in methadone maintenance therapy in-patients. ( Curry, K; Fong, D; Hines, S; Theodorou, S; Williamson, A, 2008) |
| "Environmental drug-related cues have been implicated as a cause of illicit heroin use during methadone maintenance treatment of heroin dependence." | 3.74 | Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues. ( Busch-Winokur, S; Childress, AR; Elman, I; Langleben, DD; Loughead, J; O'Brien, CP; Pratiwadi, R; Ruparel, K, 2008) |
| "We studied the effects of the commonly used mu-opioid receptor agonists morphine, oxycodone, methadone and the enantiomers of methadone in thermal and mechanical models of acute pain and in the spinal nerve ligation model of neuropathic pain in rats." | 3.73 | Morphine, oxycodone, methadone and its enantiomers in different models of nociception in the rat. ( Kalso, E; Kontinen, VK; Kylänlahti, I; Lemberg, K; Viljakka, K; Yli-Kauhaluoma, J, 2006) |
| "We describe an opioid-tolerant patient with severe acute pain which was unrelieved by morphine and ketamine via intravenous patient-controlled analgesia, but almost totally relieved by methadone." | 3.71 | Successful use of oral methadone after failure of intravenous morphine and ketamine. ( Mitchell, SJ; Sartain, JB, 2002) |
| " Among 42 active heroin users or former heroin addicts maintained on methadone, 79% were heavy alcohol abusers." | 3.65 | The spectrum and causes of liver diseases in narcotic addicts. ( Gelb, AM; Mildvan, D; Stenger, RJ, 1977) |
| "Methadone patients were hyperalgesic to pain induced by CP but not ES." | 2.70 | Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. ( Beare, CH; Bochner, F; Doverty, M; Ling, W; Menelaou, A; Somogyi, AA; White, JM, 2001) |
| "Pharmacological approaches incorporate the continuation of usual medications (or equivalent), short-term use of sometimes much higher than average doses of additional opioid, and prescription of non-opioid and adjuvant drugs, aiming to improve pain relief and attenuate opioid tolerance and/or opioid-induced hyperalgesia." | 2.47 | Acute pain management in opioid-tolerant patients: a growing challenge. ( Huxtable, CA; MacIntyre, PE; Roberts, LJ; Somogyi, AA, 2011) |
| "Undertreatment of acute pain is suboptimal medical treatment, and patients receiving long-term OAT are at particular risk." | 2.43 | Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. ( Alford, DP; Compton, P; Samet, JH, 2006) |
| "The scale of drug dependence has grown dramatically in the past quarter-century." | 2.40 | WHO Expert Committee on Drug Dependence. Thirtieth report. ( , 1998) |
| " We initiated active surveillance for cases throughout Australia, a survey of dosing points in NSW, and a case control study of clients receiving methadone syrup (MS) at two clinics." | 1.34 | An epidemiological investigation into an outbreak of rash illness among methadone maintenance clients in Australia. ( Alam, NK; Armstrong, PK; Capon, AG; Hailstone, ST; Irvine, K; Jauncey, ME; Kaldor, JM; Mannes, TF; McAnulty, JM; Monger, CK, 2007) |
| "Tramadol hydrochloride is a centrally acting analgesic with a partial affinity for the opiate receptor (mu), having an analgesic potency estimated to be one tenth that of morphine." | 1.31 | Methadone detoxification of tramadol dependence. ( DeGuiseppe, B; Leo, RJ; Narendran, R, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (37.50) | 18.7374 |
| 1990's | 2 (4.17) | 18.2507 |
| 2000's | 18 (37.50) | 29.6817 |
| 2010's | 9 (18.75) | 24.3611 |
| 2020's | 1 (2.08) | 2.80 |
| Authors | Studies |
|---|---|
| Taha, MB | 1 |
| Dasa, O | 1 |
| Al-Ani, M | 1 |
| Taha, OB | 1 |
| Radhakrishnan, NS | 1 |
| Ahmed, MM | 1 |
| Adam, VN | 1 |
| Matolić, M | 1 |
| Stojčić, EG | 1 |
| Mršić, V | 1 |
| Rašić, Ž | 1 |
| Gowing, L | 6 |
| Farrell, MF | 1 |
| Ali, R | 6 |
| White, JM | 4 |
| Martín, A | 1 |
| Tejerina, E | 1 |
| de la Cal, MA | 1 |
| Ramírez, L | 1 |
| Farrell, M | 4 |
| Mbewe, D | 1 |
| Hines, S | 1 |
| Theodorou, S | 1 |
| Williamson, A | 1 |
| Fong, D | 1 |
| Curry, K | 1 |
| Jones, HE | 1 |
| O'Grady, K | 1 |
| Dahne, J | 1 |
| Johnson, R | 1 |
| Lemoine, L | 1 |
| Milio, L | 1 |
| Ordean, A | 1 |
| Selby, P | 1 |
| Grebely, J | 1 |
| Petoumenos, K | 1 |
| Matthews, GV | 1 |
| Haber, P | 1 |
| Marks, P | 1 |
| Lloyd, AR | 1 |
| Kaldor, JM | 2 |
| Dore, GJ | 1 |
| Hellard, M | 1 |
| Constantinou, N | 1 |
| Morgan, CJ | 1 |
| Battistella, S | 1 |
| O'Ryan, D | 1 |
| Davis, P | 1 |
| Curran, HV | 1 |
| Fredheim, OM | 1 |
| Nøstdahl, T | 1 |
| Nordstrand, B | 1 |
| Høivik, T | 1 |
| Rygnestad, T | 1 |
| Borchgrevink, PC | 1 |
| Huxtable, CA | 1 |
| Roberts, LJ | 1 |
| Somogyi, AA | 2 |
| MacIntyre, PE | 1 |
| Sartain, JB | 1 |
| Mitchell, SJ | 1 |
| Holtzman, SG | 1 |
| White, J | 3 |
| Fiscella, K | 1 |
| Moore, A | 1 |
| Engerman, J | 1 |
| Meldrum, S | 1 |
| Alford, DP | 1 |
| Compton, P | 1 |
| Samet, JH | 1 |
| Lemberg, K | 1 |
| Kontinen, VK | 1 |
| Viljakka, K | 1 |
| Kylänlahti, I | 1 |
| Yli-Kauhaluoma, J | 1 |
| Kalso, E | 1 |
| McAnulty, JM | 1 |
| Jauncey, ME | 1 |
| Monger, CK | 1 |
| Hailstone, ST | 1 |
| Alam, NK | 1 |
| Mannes, TF | 1 |
| Capon, AG | 1 |
| Irvine, K | 1 |
| Armstrong, PK | 1 |
| Langleben, DD | 1 |
| Ruparel, K | 1 |
| Elman, I | 1 |
| Busch-Winokur, S | 1 |
| Pratiwadi, R | 1 |
| Loughead, J | 1 |
| O'Brien, CP | 1 |
| Childress, AR | 1 |
| Skeie, I | 1 |
| Brekke, M | 1 |
| Lindbaek, M | 1 |
| Waal, H | 1 |
| Moryl, N | 1 |
| Coyle, N | 1 |
| Foley, KM | 1 |
| Halpern, L | 1 |
| Rizzo, F | 1 |
| Birmingham, PK | 1 |
| Sembach, N | 1 |
| Levy, A | 1 |
| Masmoudi, R | 1 |
| Edel, Y | 1 |
| Gratien, M | 1 |
| Davido, A | 1 |
| Leo, RJ | 1 |
| Narendran, R | 1 |
| DeGuiseppe, B | 1 |
| Doverty, M | 1 |
| Bochner, F | 1 |
| Beare, CH | 1 |
| Menelaou, A | 1 |
| Ling, W | 1 |
| Ishiyama, A | 1 |
| Ishiyama, G | 1 |
| Baloh, RW | 1 |
| Evans, CJ | 1 |
| Gold, MS | 1 |
| Redmond, DE | 1 |
| Kleber, HD | 1 |
| Gelb, AM | 1 |
| Mildvan, D | 1 |
| Stenger, RJ | 1 |
| Mirin, SM | 1 |
| Meyer, RE | 1 |
| McNamee, HB | 1 |
| Byers, JM | 1 |
| Soin, JS | 1 |
| Fisher, RS | 1 |
| Hutchins, GM | 1 |
| Livni, N | 1 |
| Steigbuegel, D | 1 |
| Levu, IS | 1 |
| Rothbard, MJ | 1 |
| Gregory, T | 1 |
| Salerno, LJ | 1 |
| Gorman, E | 1 |
| Warfield, CA | 1 |
| Weston, MD | 1 |
| Hirsch, NP | 1 |
| Jones, JA | 1 |
| Grosz, HJ | 1 |
| Scott, ME | 1 |
| Orr, R | 1 |
| Eichhorn, A | 1 |
| Theile, U | 1 |
| Lindberg, DK | 1 |
| Malik, SK | 1 |
| Olivero, J | 1 |
| Sutherland, N | 1 |
| Dimov, D | 1 |
| Beritić, T | 1 |
| Kjeldgaard, JM | 1 |
| Hahn, GW | 1 |
| Heckenlively, JR | 1 |
| Genton, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Double Blind, Randomized Clinical Trial Comparing Postoperative Narcotic Usage in Patients Receiving Periarticular Liposomal Bupivicaine vs. Those Patients Receiving Standard Periarticular Joint Injections[NCT02682498] | Phase 4 | 38 participants (Actual) | Interventional | 2013-10-31 | Completed | ||
| Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment Who Are Undergoing Ambulatory Surgery- a Case Series[NCT04716413] | Phase 4 | 3 participants (Actual) | Interventional | 2021-09-27 | Terminated (stopped due to Terminated early due to funding, lack of participants) | ||
| Feasibility, Mechanism of Action and Potential Side Effects of Extended Release Depot Naltrexone in Opioid Dependent Patients[NCT01471145] | Phase 4 | 40 participants (Anticipated) | Interventional | 2013-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
A comparison of group means between the control group and study group with regards to 48 hour opioid use. (NCT02682498)
Timeframe: 48 hours
| Intervention | morphine equivalents (Mean) |
|---|---|
| EXPAREL® Bupivacaine Liposome Suspension | 5.32 |
| Standard Periarticular Joint Injection | 5.07 |
Opioid use will be monitored daily from the time of admission in comparison of standard knee injection post-operatively. (NCT02682498)
Timeframe: Up to 48 hours
| Intervention | Total Morphine Equivalents (Mean) |
|---|---|
| EXPAREL® Bupivacaine Liposome Suspension | 100 |
| Standard Periarticular Joint Injection | 103 |
Examining the average daily patient pain score in comparison of standard knee injection post-operatively. The measure is the Visual-Analog-Scale (VAS) for subjective pain reporting. The minimum 0 (no pain) and the maximum is 10 (worst pain imagineable). There is only one measure in the scale (i.e. there are no subscales). Lower scores on the VAS scale equate to less pain and are therefore desirable. (NCT02682498)
Timeframe: Up to 48 hours
| Intervention | Visual Analog Scale Rating (Mean) |
|---|---|
| EXPAREL® Bupivacaine Liposome Suspension | 4.75 |
| Standard Periarticular Joint Injection | 5.75 |
Examining the post-operative complication in comparison of standard knee injection post-operatively. (NCT02682498)
Timeframe: Up to 1 month
| Intervention | complications (Number) |
|---|---|
| EXPAREL® Bupivacaine Liposome Suspension | 0 |
| Standard Periarticular Joint Injection | 0 |
Post anesthesia care unit (recovery room) opioid use in total mg morphine IV equivalent in comparison of standard knee injection post-operatively. (NCT02682498)
Timeframe: Up to 48 hours
| Intervention | Total morphine equivalents (Median) |
|---|---|
| EXPAREL® Bupivacaine Liposome Suspension | 5 |
| Standard Periarticular Joint Injection | 5 |
13 reviews available for methadone and Acute Disease
| Article | Year |
|---|---|
Alpha2-adrenergic agonists for the management of opioid withdrawal.
Topics: Acute Disease; Adrenergic alpha-2 Receptor Agonists; Controlled Clinical Trials as Topic; Humans; Me | 2014 |
Alpha₂-adrenergic agonists for the management of opioid withdrawal.
Topics: Acute Disease; Adrenergic alpha-2 Receptor Agonists; Clonidine; Controlled Clinical Trials as Topic; | 2016 |
Buprenorphine for managing opioid withdrawal.
Topics: Acute Disease; Buprenorphine; Clonidine; Female; Humans; Male; Methadone; Narcotic Antagonists; Opia | 2017 |
[Treatment of acute pain during drug-assisted rehabilitation].
Topics: Acetaminophen; Acute Disease; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents | 2010 |
Acute pain management in opioid-tolerant patients: a growing challenge.
Topics: Acute Disease; Analgesics; Analgesics, Opioid; Animals; Australia; Buprenorphine; Buprenorphine, Nal | 2011 |
Alpha2 adrenergic agonists for the management of opioid withdrawal.
Topics: Acute Disease; Controlled Clinical Trials as Topic; Humans; Methadone; Narcotics; Randomized Control | 2003 |
Alpha2 adrenergic agonists for the management of opioid withdrawal.
Topics: Acute Disease; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Controlled Clinical | 2004 |
Acute pain management for patients receiving maintenance methadone or buprenorphine therapy.
Topics: Acute Disease; Adult; Analgesics, Opioid; Buprenorphine; Female; Heroin Dependence; Humans; Methadon | 2006 |
Recent advances in acute pain management.
Topics: Acute Disease; Administration, Oral; Analgesia, Epidural; Analgesia, Patient-Controlled; Analgesics; | 1995 |
WHO Expert Committee on Drug Dependence. Thirtieth report.
Topics: Acute Disease; Cost of Illness; Cost-Benefit Analysis; Health Policy; Humans; Methadone; Narcotics; | 1998 |
Alpha2 adrenergic agonists for the management of opioid withdrawal.
Topics: Acute Disease; Humans; Methadone; Narcotics; Randomized Controlled Trials as Topic; Receptors, Adren | 2001 |
The opioid-dependent patient with acute pain.
Topics: Acute Disease; Humans; Methadone; Narcotics; Opioid-Related Disorders; Pain; Pain, Postoperative; Su | 1987 |
[Antitussive agents. 34].
Topics: Acetylcysteine; Acute Disease; Alkaloids; Animals; Antitussive Agents; Bronchitis; Central Nervous S | 1969 |
5 trials available for methadone and Acute Disease
| Article | Year |
|---|---|
Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study.
Topics: Acute Disease; Adult; Antiviral Agents; Australia; Cohort Studies; Female; Hepacivirus; Hepatitis C; | 2010 |
Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine.
Topics: Acute Disease; Adult; Analgesics, Opioid; Cold Temperature; Drug Interactions; Drug Tolerance; Elect | 2001 |
Clonidine blocks acute opiate-withdrawal symptoms.
Topics: Acute Disease; Clinical Trials as Topic; Clonidine; Double-Blind Method; Drug Evaluation; Follow-Up | 1978 |
Narcotic withdrawal symptoms in heroin users treated with propranolol.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Clinical Trials as Topic; Female; Heroin; Hu | 1972 |
Effects of diamorphine, methadone, morphine, and pentazocine in patients with suspected acute myocardial infarction.
Topics: Acute Disease; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Female; Heart Rate; Heroin; Hu | 1969 |
30 other studies available for methadone and Acute Disease
| Article | Year |
|---|---|
Acute right ventricular failure: a novel presentation of methadone-induced cardiotoxicity.
Topics: Acute Disease; Antitussive Agents; Cardiotoxicity; Drug Overdose; Female; Heart Failure; Humans; Met | 2020 |
[ACUTE PAIN MANAGEMENT IN PATIENT ON OPIOID SUBSTITUTION THERAPY WITH\
METHADONE OR BUPRENORPHINE].
Topics: Acute Disease; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Pain; Pain Managemen | 2016 |
Acute hydrocephalus secondary to carbon monoxide poisoning.
Topics: Acute Disease; Adult; Benzodiazepines; Carbon Monoxide Poisoning; Humans; Hydrocephalus; Magnetic Re | 2016 |
Management of acute pain in methadone maintenance therapy in-patients.
Topics: Acute Disease; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Australia; Dose-Response Relatio | 2008 |
Management of acute postpartum pain in patients maintained on methadone or buprenorphine during pregnancy.
Topics: Acute Disease; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Buprenorphine; Controlled Clinic | 2009 |
Attentional bias, inhibitory control and acute stress in current and former opiate addicts.
Topics: Acute Disease; Adult; Attention; Employment; Female; Humans; Inhibition, Psychological; Male; Mental | 2010 |
Successful use of oral methadone after failure of intravenous morphine and ketamine.
Topics: Acute Disease; Administration, Oral; Adult; Analgesia, Patient-Controlled; Analgesics; Analgesics, O | 2002 |
Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
Topics: Acute Disease; Analgesics, Opioid; Animals; Disease Models, Animal; Fentanyl; Male; Methadone; Morph | 2003 |
Management of opiate detoxification in jails.
Topics: Acute Disease; Adrenergic alpha-Agonists; Clonidine; Health Care Surveys; Humans; Methadone; Narcoti | 2005 |
Morphine, oxycodone, methadone and its enantiomers in different models of nociception in the rat.
Topics: Acute Disease; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Male; Methadone; Morph | 2006 |
An epidemiological investigation into an outbreak of rash illness among methadone maintenance clients in Australia.
Topics: Acute Disease; Administration, Oral; Adult; Australia; Case-Control Studies; Causality; Cross-Sectio | 2007 |
Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues.
Topics: Acute Disease; Adult; Analgesics, Opioid; Behavior, Addictive; Brain; Cues; Dose-Response Relationsh | 2008 |
Somatic health among heroin addicts before and during opioid maintenance treatment: a retrospective cohort study.
Topics: Acute Disease; Adult; Ambulatory Care; Chronic Disease; Cohort Studies; Drug Overdose; Female; Healt | 2008 |
Managing an acute pain crisis in a patient with advanced cancer: "this is as much of a crisis as a code".
Topics: Acute Disease; Adenocarcinoma, Mucinous; Adjuvants, Anesthesia; Adult; Analgesics, Opioid; Anestheti | 2008 |
Substitution-detoxification and its role in the management of chronic benign pain.
Topics: Acute Disease; Analgesics, Opioid; Chronic Disease; Drug Administration Schedule; Humans; Hypnotics | 1982 |
[The need for psychopharmacologic therapy of drug addicts with acute hepatitis].
Topics: Acute Disease; Diazepam; Drug Therapy, Combination; Hepatitis; Heroin Dependence; Humans; Methadone; | 1984 |
[Acute methadone poisoning].
Topics: Acute Disease; Adult; Depressive Disorder; Humans; Male; Methadone; Naloxone; Narcotic Antagonists; | 2000 |
Methadone detoxification of tramadol dependence.
Topics: Acute Disease; Dose-Response Relationship, Drug; Female; Humans; Methadone; Middle Aged; Opioid-Rela | 2000 |
Heroin-induced reversible profound deafness and vestibular dysfunction.
Topics: Acute Disease; Deafness; Heroin; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Narcotics; | 2001 |
The spectrum and causes of liver diseases in narcotic addicts.
Topics: Acute Disease; Alcoholism; Biopsy, Needle; Chemical and Drug Induced Liver Injury; Chronic Disease; | 1977 |
Psychopathology and mood during heroin use: acute vs chronic effects.
Topics: Acute Disease; Adult; Chronic Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; | 1976 |
Acute pulmonary alveolitis in narcotics abuse.
Topics: Acute Disease; Adolescent; Adult; Angiography; Cocaine; Female; Foreign Bodies; Foreign-Body Reactio | 1975 |
Viral hepatitis with intracytoplasmic cholestasis and cholesterol crystals in a drug addict.
Topics: Acute Disease; Adolescent; Cholestasis; Cholesterol; Crystallization; Cytoplasm; Diazepam; Female; H | 1975 |
Intrapartum gonococcal amnionitis.
Topics: Acute Disease; Adult; Amnion; Apgar Score; Female; Gonorrhea; Heroin Dependence; Humans; Infant, New | 1975 |
Narcotic overdose and acute rhabdomyolysis.
Topics: Acute Disease; Adult; Humans; Male; Methadone; Rhabdomyolysis | 1986 |
[Therapy of acute pericarditis].
Topics: Acute Disease; Aminopyrine; Antitubercular Agents; Aspirin; Cardiac Tamponade; Chlordiazepoxide; Dia | 1973 |
Pentazocine in methadone hydrochloride maintenance.
Topics: Acute Disease; Administration, Oral; Humans; Injections, Intravenous; Methadone; Pentazocine; Substa | 1973 |
Pulmonary edema and oral ingestion of methadone.
Topics: Acute Disease; Administration, Oral; Adolescent; Humans; Male; Methadone; Pulmonary Edema | 1972 |
[Acute poisoning by methadone (Heptanon)].
Topics: Acute Disease; Child; Humans; Methadone; Poisoning | 1971 |
Methadone-induced pulmonary edema.
Topics: Acute Disease; Administration, Oral; Adult; Coma; Female; Furosemide; Heroin; Humans; Hydrocortisone | 1971 |